xista science ventures

Syntropic Medical is a medical device company dedicated to developing innovative technologies aimed at treating psychiatric diseases and enhancing cognitive abilities. The company focuses on advancing mental health care by targeting the underlying causes of brain disorders, with a particular emphasis on enhancing the brain's neuroplasticity. Syntropic Medical's approach enables individuals to access non-invasive and non-pharmaceutical treatments for mental health disorders, promoting improved mental well-being and cognitive function.

G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. It specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses that cause common colds and flu infections. The company's innovative approach involves using a host cell-based strategy to create broad-spectrum antivirals. Its lead therapy utilizes 2-deoxyglucose to disrupt the viral exploitation of host cell metabolism, thereby impeding viral replication both in vitro and in vivo, particularly against rhinoviruses. This method aims to starve viruses by interrupting their nutrient supply, offering a novel treatment for patients with viral diseases.

Hephaistos Pharma is a biotechnology firm dedicated to advancing oncology treatments through innovative immunotherapy solutions. The company focuses on developing next-generation therapies that utilize active and non-specific immuno-stimulants, which enhance the efficacy of existing antibodies and transform cold tumors into hot targets for the immune system. By addressing unmet medical needs, Hephaistos Pharma aims to provide effective treatment options for patients with incurable cancers. Their platform is designed to stimulate immune responses, thereby improving the overall efficiency of immunotherapy. The firm also offers an online inquiry form on its website for further engagement.

Rivus Batteries is an innovative green technology company dedicated to advancing sustainable energy storage solutions through its unique metal-free flow battery technology. The company specializes in developing novel organic electrolytes made from abundantly available elements, which can be synthesized on a large scale while maintaining a low environmental footprint. Rivus focuses on providing cost-effective and environmentally friendly alternatives for long-duration energy storage, positioning itself as a leader in the field of eco-friendly grid-scale energy solutions. By utilizing water-based organic electrolytes, Rivus aims to reduce both costs and the environmental impact associated with traditional energy storage technologies.

VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

Infrared.city is a technology company that empowers stakeholders in the built environment with AI-driven climate simulations. Its platform offers real-time, understandable insights into a design's resilience against various climate factors, such as wind, heat, and solar radiation. This enables architects, engineers, urban planners, and policymakers to make informed decisions throughout the design process, fostering more resilient and sustainable cities.

subdron focuses on data processing in underwater inspections and autonomous underwater navigation.

ReCatalyst is a company focused on the development and commercialization of advanced catalysts for hydrogen fuel cells. It specializes in platinum-alloy catalysts, offering patented nano-catalyst technology that enhances stability and reduces the amount of platinum required in fuel cell systems. This innovation enables greater scalability of high-power proton exchange membrane fuel cells while optimizing the use of platinum group metals. By improving the efficiency and sustainability of fuel cell technology, ReCatalyst aims to contribute significantly to the growing hydrogen energy sector.

Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.

Sarcura GmbH is an Austrian deep-tech startup founded in 2019, specializing in the development of a machine platform for the large-scale, industrial manufacturing of personalized cell therapies aimed at treating cancer. The company employs advanced semiconductor technology and microfluidic processing to facilitate real-time process control and manipulation at the cellular level. This innovative approach enables a fully automated and modular manufacturing system, enhancing the efficiency and safety of cell therapies while making them more cost-effective for patients. Based in Hinterstoder, Austria, Sarcura is poised to transform manufacturing paradigms in the field of patient-specific cancer treatment.

Brightmind.ai is a developer of advanced neuromodulation technology focused on improving brain health through innovative, personalized solutions. The company harnesses artificial intelligence to deliver tailored brain stimulation that targets individual brain wave oscillations. By continuously measuring biofeedback, Brightmind.ai enhances the effectiveness of its therapies for the central nervous system. This approach aims to address significant brain health challenges, such as pain relief, cognitive decline, and depression. The company's initial focus is on migraine treatment, where it has identified a substantial dissatisfaction with current options among patients. Research indicates that Brightmind.ai's stimulation protocol can reduce migraine attacks by over 50% for a significant percentage of sufferers. With a vision of making its neurotechnology accessible in homes globally, Brightmind.ai seeks to transform the landscape of brain health management.

Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.

Brainhero is a life science company that specializes in home-based neurofeedback therapy aimed at assisting individuals with neurological impairments, particularly children diagnosed with Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD). The company utilizes an innovative approach that enables users to train their brain activity through an engaging and playful interface. By measuring brain waves with an electroencephalogram (EEG) and visualizing the data in a mobile application, children can learn to enhance their concentration and relaxation skills. Brainhero's services also support medical practitioners in early prediction of neurological issues and in adjusting medication dosages for patients experiencing various conditions, including intellectual disabilities, epilepsy, and anxiety.

CellEctric is a biotechnology company established in early 2021, focused on integrating electrodynamics with biological applications. The company is developing an innovative platform designed to enhance the efficiency and precision of life science processes, particularly in the analysis of complex biological samples. Their current project emphasizes the rapid isolation of viable bacteria from human samples to facilitate faster diagnosis of sepsis. This platform utilizes advanced technology to provide flexible and specific biological sample preparation, allowing for the targeted removal of unwanted cells that impede accurate detection. CellEctric aims to revolutionize laboratory practices by offering a customizable solution for high-throughput separation of similar mammalian cell populations, thereby improving the speed and automation of cell manipulation in research and clinical settings.

Ribbon Biolabs GmbH is a Vienna, Austria-based company founded in 2018 that specializes in the synthesis of long DNA molecules. The company aims to advance molecular biology by developing innovative methods for DNA synthesis, enabling the creation and exploration of genetic solutions through high-throughput synthesis of unprecedentedly long DNA sequences. Ribbon Biolabs' technology supports a wide range of applications, including genome construction, high-throughput libraries, DNA-based data storage and computing, and the development of DNA nanotechnologies. This allows researchers and companies to work with extensive DNA libraries without economic or time constraints.

Nista.io is a technology company that specializes in developing a cloud-based platform aimed at optimizing energy consumption and reducing emissions for industrial businesses. The platform analyzes energy data from manufacturing facilities to identify actionable improvements, helping companies lower their annual energy costs by up to 20 percent. By continuously monitoring and integrating data from factories, Nista.io empowers organizations to make informed operational decisions that enhance energy efficiency and contribute to long-term reductions in carbon dioxide emissions.

VitreaLab GmbH, founded in 2018 and based in Vienna, Austria, specializes in the development of advanced laser-powered photonic integrated circuits that aim to revolutionize display technology. The company manufactures liquid-crystal display (LCD) backlights utilizing glass-based waveguides to control and transport visible light with precision. Its innovative quantum light chip serves as a high-performance light source, delivering exceptional brightness and color quality for 3D, virtual reality, and augmented reality applications while consuming significantly less energy than traditional technologies. By replacing standard backlight units with its proprietary circuits, VitreaLab enhances LCD performance in energy efficiency, brightness, contrast ratio, and color rendering, enabling superior laser displays and immersive 3D imagery without the need for goggles.

Contextflow GmbH is a Vienna-based company that specializes in developing machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, Contextflow has created a 3D image-based search engine that allows radiologists to quickly identify regions of interest within medical images, specifically targeting over 18 patterns in lung CT scans. The technology enables the rapid retrieval of visually similar cases, relevant descriptions, and differential diagnoses, thereby streamlining the decision-making process for healthcare professionals. Contextflow's software enhances diagnostic workflows and integrates seamlessly into existing PACS systems, ultimately improving patient care. The company has formed strategic partnerships with notable organizations, including the Radiology Center and Boehringer Ingelheim, and has garnered recognition for its innovative approach, such as being awarded the Most Promising Startup distinction. Currently, Contextflow is testing its solutions with multiple partners and aims to expand its international presence in the near future.

Rivus Batteries is an innovative green technology company dedicated to advancing sustainable energy storage solutions through its unique metal-free flow battery technology. The company specializes in developing novel organic electrolytes made from abundantly available elements, which can be synthesized on a large scale while maintaining a low environmental footprint. Rivus focuses on providing cost-effective and environmentally friendly alternatives for long-duration energy storage, positioning itself as a leader in the field of eco-friendly grid-scale energy solutions. By utilizing water-based organic electrolytes, Rivus aims to reduce both costs and the environmental impact associated with traditional energy storage technologies.

Sarcura GmbH is an Austrian deep-tech startup founded in 2019, specializing in the development of a machine platform for the large-scale, industrial manufacturing of personalized cell therapies aimed at treating cancer. The company employs advanced semiconductor technology and microfluidic processing to facilitate real-time process control and manipulation at the cellular level. This innovative approach enables a fully automated and modular manufacturing system, enhancing the efficiency and safety of cell therapies while making them more cost-effective for patients. Based in Hinterstoder, Austria, Sarcura is poised to transform manufacturing paradigms in the field of patient-specific cancer treatment.

Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.

VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. It specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses that cause common colds and flu infections. The company's innovative approach involves using a host cell-based strategy to create broad-spectrum antivirals. Its lead therapy utilizes 2-deoxyglucose to disrupt the viral exploitation of host cell metabolism, thereby impeding viral replication both in vitro and in vivo, particularly against rhinoviruses. This method aims to starve viruses by interrupting their nutrient supply, offering a novel treatment for patients with viral diseases.

VitreaLab GmbH, founded in 2018 and based in Vienna, Austria, specializes in the development of advanced laser-powered photonic integrated circuits that aim to revolutionize display technology. The company manufactures liquid-crystal display (LCD) backlights utilizing glass-based waveguides to control and transport visible light with precision. Its innovative quantum light chip serves as a high-performance light source, delivering exceptional brightness and color quality for 3D, virtual reality, and augmented reality applications while consuming significantly less energy than traditional technologies. By replacing standard backlight units with its proprietary circuits, VitreaLab enhances LCD performance in energy efficiency, brightness, contrast ratio, and color rendering, enabling superior laser displays and immersive 3D imagery without the need for goggles.

Ribbon Biolabs GmbH is a Vienna, Austria-based company founded in 2018 that specializes in the synthesis of long DNA molecules. The company aims to advance molecular biology by developing innovative methods for DNA synthesis, enabling the creation and exploration of genetic solutions through high-throughput synthesis of unprecedentedly long DNA sequences. Ribbon Biolabs' technology supports a wide range of applications, including genome construction, high-throughput libraries, DNA-based data storage and computing, and the development of DNA nanotechnologies. This allows researchers and companies to work with extensive DNA libraries without economic or time constraints.

Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.

Contextflow GmbH is a Vienna-based company that specializes in developing machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, Contextflow has created a 3D image-based search engine that allows radiologists to quickly identify regions of interest within medical images, specifically targeting over 18 patterns in lung CT scans. The technology enables the rapid retrieval of visually similar cases, relevant descriptions, and differential diagnoses, thereby streamlining the decision-making process for healthcare professionals. Contextflow's software enhances diagnostic workflows and integrates seamlessly into existing PACS systems, ultimately improving patient care. The company has formed strategic partnerships with notable organizations, including the Radiology Center and Boehringer Ingelheim, and has garnered recognition for its innovative approach, such as being awarded the Most Promising Startup distinction. Currently, Contextflow is testing its solutions with multiple partners and aims to expand its international presence in the near future.